Insider Transactions in Q2 2022 at Mind Medicine (Mind Med) Inc. (MNMD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,238
-0.64%
|
$0
$0.7 P/Share
|
|
Jun 27
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,762
-0.93%
|
$0
$0.7 P/Share
|
|
Jun 16
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,275
-0.54%
|
$0
$0.7 P/Share
|
|
Jun 01
2022
|
Andreas Krebs |
BUY
Grant, award, or other acquisition
|
Direct |
21,552
+50.0%
|
-
|
|
Jun 01
2022
|
Brigid Makes Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,656
+28.95%
|
-
|
|
Jun 01
2022
|
Carol A Vallone |
BUY
Grant, award, or other acquisition
|
Direct |
43,104
+50.0%
|
-
|
|
May 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,555
-0.23%
|
$0
$0.82 P/Share
|
|
May 25
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,242
-0.2%
|
$0
$0.77 P/Share
|
|
May 25
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,415
-0.46%
|
$0
$0.77 P/Share
|
|
May 23
2022
|
Schond L. Greenway Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,270,000
+50.0%
|
-
|
|
May 15
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,948
-0.47%
|
$0
$0.82 P/Share
|
|
May 11
2022
|
Brigid Makes Director |
BUY
Other acquisition or disposition
|
Direct |
67,678
+41.85%
|
-
|
|
Apr 26
2022
|
Dan Karlin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,038
-0.32%
|
$0
$0.81 P/Share
|
|
Apr 18
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,110
-0.47%
|
$0
$0.92 P/Share
|